Literature DB >> 33248259

Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.

Pierrick Bourgeat1, Vincent Doré2, James Doecke3, David Ames4, Colin L Masters5, Christopher C Rowe6, Jurgen Fripp3, Victor L Villemagne6.   

Abstract

BACKGROUND: Centiloid was introduced to harmonise β-Amyloid (Aβ) PET quantification across different tracers, scanners and analysis techniques. Unfortunately, Centiloid still suffers from some quantification disparities in longitudinal analysis when normalising data from different tracers or scanners. In this work, we aim to reduce this variability using a different analysis technique applied to the existing calibration data.
METHOD: All PET images from the Centiloid calibration dataset, along with 3762 PET images from the AIBL study were analysed using the recommended SPM pipeline. The PET images were SUVR normalised using the whole cerebellum. All SUVR normalised PiB images from the calibration dataset were decomposed using non-negative matrix factorisation (NMF). The NMF coefficients related to the first component were strongly correlated with global SUVR and were subsequently used as a surrogate for Aβ retention. For each tracer of the calibration dataset, the components of the NMF were computed in a way such that the coefficients of the first component would match those of the corresponding PiB. Given the strong correlations between the SUVR and the NMF coefficients on the calibration dataset, all PET images from AIBL were subsequently decomposed using the computed NMF, and their coefficients transformed into Centiloids.
RESULTS: Using the AIBL data, the correlation between the standard Centiloid and the novel NMF-based Centiloid was high in each tracer. The NMF-based Centiloids showed a reduction of outliers, and improved longitudinal consistency. Furthermore, it removed the effects of switching tracers from the longitudinal variance of the Centiloid measure, when assessed using a linear mixed effects model.
CONCLUSION: We here propose a novel image driven method to perform the Centiloid quantification. The methods is highly correlated with standard Centiloids while improving the longitudinal reliability when switching tracers. Implementation of this method across multiple studies may lend to more robust and comparable data for future research.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Aβ Imaging; Centiloid

Mesh:

Substances:

Year:  2020        PMID: 33248259      PMCID: PMC8049633          DOI: 10.1016/j.neuroimage.2020.117593

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  15 in total

1.  Learning the parts of objects by non-negative matrix factorization.

Authors:  D D Lee; H S Seung
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging.

Authors:  Alex Whittington; Roger N Gunn
Journal:  J Nucl Med       Date:  2018-09-06       Impact factor: 10.057

3.  The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.

Authors:  William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun
Journal:  Alzheimers Dement       Date:  2014-10-28       Impact factor: 21.566

4.  Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.

Authors:  Jurgen Fripp; Pierrick Bourgeat; Oscar Acosta; Parnesh Raniga; Marc Modat; Kerryn E Pike; Gareth Jones; Graeme O'Keefe; Colin L Masters; David Ames; Kathryn A Ellis; Paul Maruff; Jon Currie; Victor L Villemagne; Christopher C Rowe; Olivier Salvado; Sébastien Ourselin
Journal:  Neuroimage       Date:  2008-08-12       Impact factor: 6.556

5.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

6.  Reducing between scanner differences in multi-center PET studies.

Authors:  Aniket Joshi; Robert A Koeppe; Jeffrey A Fessler
Journal:  Neuroimage       Date:  2009-02-06       Impact factor: 6.556

7.  Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.

Authors:  Tomotaka Tanaka; Mary C Stephenson; Ying-Hwey Nai; Damian Khor; Francis N Saridin; Saima Hilal; Steven Villaraza; Bibek Gyanwali; Masafumi Ihara; Henri Vrooman; Ashley A Weekes; John J Totman; Edward G Robins; Christopher P Chen; Anthonin Reilhac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-20       Impact factor: 9.236

8.  18F-Florbetaben PET beta-amyloid binding expressed in Centiloids.

Authors:  Christopher C Rowe; Vincent Doré; Gareth Jones; David Baxendale; Rachel S Mulligan; Santiago Bullich; Andrew W Stephens; Susan De Santi; Colin L Masters; Ludger Dinkelborg; Victor L Villemagne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-22       Impact factor: 9.236

9.  Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods.

Authors:  Mark R Battle; Lovena Chedumbarum Pillay; Val J Lowe; David Knopman; Bradley Kemp; Christopher C Rowe; Vincent Doré; Victor L Villemagne; Christopher J Buckley
Journal:  EJNMMI Res       Date:  2018-12-05       Impact factor: 3.138

10.  Spatial Normalization of 18F-Flutemetamol PET Images Using an Adaptive Principal-Component Template

Authors:  Johan Lilja; Antoine Leuzy; Konstantinos Chiotis; Irina Savitcheva; Jens Sörensen; Agneta Nordberg
Journal:  J Nucl Med       Date:  2018-06-14       Impact factor: 10.057

View more
  2 in total

1.  β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.

Authors:  Pierrick Bourgeat; Vincent Doré; Samantha C Burnham; Tammie Benzinger; Duygu Tosun; Shenpeng Li; Manu Goyal; Pamela LaMontagne; Liang Jin; Christopher C Rowe; Michael W Weiner; John C Morris; Colin L Masters; Jurgen Fripp; Victor L Villemagne
Journal:  Neuroimage       Date:  2022-07-30       Impact factor: 7.400

Review 2.  Quantification of amyloid PET for future clinical use: a state-of-the-art review.

Authors:  Hugh G Pemberton; Lyduine E Collij; Fiona Heeman; Ariane Bollack; Mahnaz Shekari; Gemma Salvadó; Isadora Lopes Alves; David Vallez Garcia; Mark Battle; Christopher Buckley; Andrew W Stephens; Santiago Bullich; Valentina Garibotto; Frederik Barkhof; Juan Domingo Gispert; Gill Farrar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-07       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.